| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 5,320 | 6,707 | ||
| General and administrative | 9,372 | 5,856 | ||
| Total operating expenses | 14,692 | 12,563 | ||
| Interest income | 554 | 192 | ||
| Interest expense note 6 | 192 | 191 | ||
| Change in fair value of contingent consideration note 4 and note 5 | 106 | 97 | ||
| Other expense | -5 | -59 | ||
| Total other income (expense) | 251 | -155 | ||
| Net loss | -14,441 | -12,718 | ||
| Net unrealized loss on marketable securities | 6 | -3 | ||
| Total other comprehensive loss | 6 | -3 | ||
| Comprehensive loss | -14,435 | -12,721 | ||
| Earnings per share, basic, total | -0.28 | -0.37 | ||
| Earnings per share, diluted, total | -0.28 | -0.37 | ||
| Weighted average number of shares outstanding, basic, total | 51,017,662 | 34,685,072 | ||
| Weighted average number of shares outstanding, diluted, total | 51,017,662 | 34,685,072 | ||
ACHIEVE LIFE SCIENCES, INC. (ACHV)
ACHIEVE LIFE SCIENCES, INC. (ACHV)